HC Wainwright & Co. Initiates Coverage On Candel Therapeutics With Buy Rating, Announces Price Target of $11
HC Wainwright & Co. Initiates Coverage On Candel Therapeutics With Buy Rating, Announces Price Target of $11
HC Wainwright&Co.以買入評級啟動對Candel治療公司的報道，宣佈目標價為11美元
HC Wainwright & Co. analyst Vernon Bernardino initiates coverage on Candel Therapeutics (NASDAQ:CADL) with a Buy rating and announces Price Target of $11.
HC Wainwright&Co.分析師Vernon Bernardino以買入評級啟動對Candel Treateutics(納斯達克：CADL)的報道，並宣佈目標價為11美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。